Home RxNorm 1048340 hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urelle] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1048340
RxNorm name hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urelle]
Display name URELLE (Oral Pill)
Full name hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urelle]
Term type SBD
Status Active
Strength 0.12-81-10.8-32.4-40.8 mg
Dose form Tab
Route Oral Pill
Updated 2026-08-03 17:30:49 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 012011
Active start 012011
Multiple ingredient YES
Branded YES Ingredients And Strength# Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 0037-6321-90 0037-6321 URELLE hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrate Viatris Specialty LLC
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.
NDC11, Source, Active table NDC11 Source Active 00037632190 rxnav_ndcs yes 66663021901 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join URELLE HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Viatris Specialty LLC 1d80a11c-6f86-403b-85d4-32ec1924dbe9 2015-01-13 Warnings, Adverse reactions Exact identifier ndc (package): 0037-6321-90 ndc (product): 0037-6321 ndc11 (package): 00037632190 rxcui: 1048340
DailyMed RxNorm Mappings# Set ID, RxNorm string, TTY table Set ID RxNorm string TTY SPL version Label Effective 1d80a11c-6f86-403b-85d4-32ec1924dbe9 hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urelle] SBD 4 URELLE ® Urinary Antiseptic 20150113 1d80a11c-6f86-403b-85d4-32ec1924dbe9 Urelle (hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet SY 4 URELLE ® Urinary Antiseptic 20150113 1d80a11c-6f86-403b-85d4-32ec1924dbe9 urelle Urinary Antiseptic 0.12 MG / 81 MG / 10.8 MG / 32.4 MG / 40.8 MG Oral Tablet PSN 4 URELLE ® Urinary Antiseptic 20150113
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC V03AB Antidotes ATC1-4 methylene blue ATC A03BA Belladonna alkaloids, tertiary amines ATC1-4 hyoscyamine ATC J01XX Other antibacterials ATC1-4 methenamine ATC G04BX Other urologicals ATC1-4 phenyl salicylate ATC V04CG Tests for gastric secretion ATC1-4 methylene blue MEDRT D064692 Hyoscyamine CHEM has_ingredient hyoscyamine sulfate MEDRT D064692 Hyoscyamine CHEM has_ingredient hyoscyamine MEDRT D008709 Methenamine CHEM has_ingredient methenamine MEDRT D008751 Methylene Blue CHEM has_ingredient methylene blue MEDRT D010710 Phosphates CHEM has_ingredient sodium phosphate, monobasic MEDRT D012459 Salicylates CHEM has_ingredient phenyl salicylate MEDRT D013449 Sulfonamides CHEM ci_chemclass methenamine MEDRT D000014 Abnormalities, Drug-Induced DISEASE may_treat hyoscyamine sulfate MEDRT D000014 Abnormalities, Drug-Induced DISEASE may_treat hyoscyamine MEDRT D000471 Alkalosis DISEASE ci_with sodium phosphate, monobasic MEDRT D001437 Bacteriuria DISEASE may_treat methenamine MEDRT D003085 Colic DISEASE may_treat hyoscyamine MEDRT D003085 Colic DISEASE may_treat hyoscyamine sulfate MEDRT D003093 Colitis, Ulcerative DISEASE ci_with hyoscyamine MEDRT D003093 Colitis, Ulcerative DISEASE ci_with hyoscyamine sulfate MEDRT D003248 Constipation DISEASE may_treat sodium phosphate, monobasic MEDRT D003490 Cyanosis DISEASE may_treat methylene blue MEDRT D003490 Cyanosis DISEASE may_prevent methylene blue MEDRT D003556 Cystitis DISEASE may_treat methenamine MEDRT D003681 Dehydration DISEASE ci_with methenamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with methylene blue MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hyoscyamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hyoscyamine sulfate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with phenyl salicylate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with sodium phosphate, monobasic MEDRT D004487 Edema DISEASE ci_with sodium phosphate, monobasic MEDRT D004927 Escherichia coli Infections DISEASE may_treat methenamine MEDRT D005334 Fever DISEASE may_treat phenyl salicylate MEDRT D018589 Gastroparesis DISEASE induces hyoscyamine MEDRT D018589 Gastroparesis DISEASE induces hyoscyamine sulfate MEDRT D005901 Glaucoma DISEASE ci_with hyoscyamine MEDRT D005901 Glaucoma DISEASE ci_with hyoscyamine sulfate MEDRT D048550 Hepatic Insufficiency DISEASE ci_with methenamine MEDRT D006561 Herpes Simplex DISEASE may_treat methylene blue MEDRT D006945 Hyperhidrosis DISEASE may_treat hyoscyamine MEDRT D006945 Hyperhidrosis DISEASE may_treat hyoscyamine sulfate MEDRT D006955 Hypernatremia DISEASE ci_with sodium phosphate, monobasic MEDRT D006967 Hypersensitivity DISEASE ci_with methenamine MEDRT D006996 Hypocalcemia DISEASE ci_with sodium phosphate, monobasic MEDRT D017674 Hypophosphatemia DISEASE may_prevent sodium phosphate, monobasic MEDRT D017674 Hypophosphatemia DISEASE may_treat sodium phosphate, monobasic MEDRT D007077 Ileal Diseases DISEASE ci_with hyoscyamine MEDRT D007077 Ileal Diseases DISEASE ci_with hyoscyamine sulfate MEDRT D007415 Intestinal Obstruction DISEASE ci_with hyoscyamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with hyoscyamine sulfate MEDRT D007431 Intraoperative Complications DISEASE may_treat hyoscyamine sulfate MEDRT D007431 Intraoperative Complications DISEASE may_treat hyoscyamine MEDRT D043183 Irritable Bowel Syndrome DISEASE may_treat hyoscyamine MEDRT D043183 Irritable Bowel Syndrome DISEASE may_treat hyoscyamine sulfate MEDRT D007674 Kidney Diseases DISEASE ci_with methenamine MEDRT D020347 Lithiasis DISEASE may_treat methylene blue MEDRT D008532 Megacolon, Toxic DISEASE ci_with hyoscyamine sulfate MEDRT D008532 Megacolon, Toxic DISEASE ci_with hyoscyamine MEDRT D008708 Methemoglobinemia DISEASE may_treat methylene blue MEDRT D008708 Methemoglobinemia DISEASE induces methylene blue MEDRT D009127 Muscle Rigidity DISEASE may_treat hyoscyamine sulfate MEDRT D009127 Muscle Rigidity DISEASE may_treat hyoscyamine MEDRT D009157 Myasthenia Gravis DISEASE ci_with hyoscyamine sulfate MEDRT D009157 Myasthenia Gravis DISEASE ci_with hyoscyamine MEDRT D017202 Myocardial Ischemia DISEASE ci_with hyoscyamine MEDRT D017202 Myocardial Ischemia DISEASE ci_with hyoscyamine sulfate MEDRT D010146 Pain DISEASE may_prevent phenyl salicylate MEDRT D010146 Pain DISEASE may_treat phenyl salicylate MEDRT D010437 Peptic Ulcer DISEASE may_treat hyoscyamine sulfate MEDRT D010437 Peptic Ulcer DISEASE may_treat hyoscyamine MEDRT D011041 Poisoning DISEASE may_treat methylene blue MEDRT D011247 Pregnancy DISEASE ci_with methylene blue MEDRT D011654 Pulmonary Edema DISEASE ci_with sodium phosphate, monobasic MEDRT D051437 Renal Insufficiency DISEASE ci_with sodium phosphate, monobasic MEDRT D051437 Renal Insufficiency DISEASE ci_with methylene blue MEDRT D012220 Rhinitis DISEASE may_treat hyoscyamine sulfate MEDRT D012220 Rhinitis DISEASE may_treat hyoscyamine MEDRT D012771 Shock, Hemorrhagic DISEASE ci_with hyoscyamine MEDRT D012771 Shock, Hemorrhagic DISEASE ci_with hyoscyamine sulfate MEDRT D012798 Sialorrhea DISEASE may_treat hyoscyamine MEDRT D012798 Sialorrhea DISEASE may_treat hyoscyamine sulfate MEDRT D013035 Spasm DISEASE may_treat hyoscyamine MEDRT D013035 Spasm DISEASE may_treat hyoscyamine sulfate MEDRT D013203 Staphylococcal Infections DISEASE may_treat methenamine MEDRT D014202 Tremor DISEASE may_treat hyoscyamine MEDRT D014202 Tremor DISEASE may_treat hyoscyamine sulfate MEDRT D014524 Urethral Obstruction DISEASE ci_with hyoscyamine MEDRT D014524 Urethral Obstruction DISEASE ci_with hyoscyamine sulfate MEDRT D001750 Urinary Bladder, Neurogenic DISEASE may_treat hyoscyamine sulfate MEDRT D001750 Urinary Bladder, Neurogenic DISEASE may_treat hyoscyamine MEDRT D014552 Urinary Tract Infections DISEASE may_prevent methenamine MEDRT D014552 Urinary Tract Infections DISEASE may_treat methylene blue MEDRT D020924 Urological Manifestations DISEASE may_treat sodium phosphate, monobasic MEDRT D014987 Xerostomia DISEASE induces hyoscyamine MEDRT D014987 Xerostomia DISEASE induces hyoscyamine sulfate MEDRT N0000000236 Alkylating Activity MOA has_moa methylene blue MEDRT N0000175355 Binding Activity MOA has_moa methylene blue MEDRT N0000000125 Cholinergic Muscarinic Antagonists MOA has_moa hyoscyamine MEDRT N0000000125 Cholinergic Muscarinic Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000000160 Cyclooxygenase Inhibitors MOA has_moa phenyl salicylate MEDRT N0000000220 Electrolyte Activity MOA has_moa sodium phosphate, monobasic MEDRT N0000000207 Histamine Receptor Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000000207 Histamine Receptor Antagonists MOA has_moa hyoscyamine MEDRT N0000010288 Osmotic Activity MOA has_moa sodium phosphate, monobasic MEDRT N0000000130 Serotonin Antagonists MOA has_moa hyoscyamine MEDRT N0000000130 Serotonin Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000008331 Cardiovascular Activity Alteration PE has_pe hyoscyamine MEDRT N0000008331 Cardiovascular Activity Alteration PE has_pe hyoscyamine sulfate MEDRT N0000008337 Cellular Activity Alteration PE has_pe sodium phosphate, monobasic MEDRT N0000008337 Cellular Activity Alteration PE has_pe methenamine MEDRT N0000008337 Cellular Activity Alteration PE has_pe methylene blue MEDRT N0000008832 Decreased Platelet Aggregation PE has_pe phenyl salicylate MEDRT N0000008836 Decreased Prostaglandin Production PE has_pe phenyl salicylate MEDRT N0000008868 Decreased Respiratory Secretions PE has_pe hyoscyamine MEDRT N0000008868 Decreased Respiratory Secretions PE has_pe hyoscyamine sulfate MEDRT N0000009006 Decreased Thromboxane Production PE has_pe phenyl salicylate MEDRT N0000009371 Increased Large Intestinal Motility PE has_pe sodium phosphate, monobasic MEDRT N0000009399 Increased Metabolic Rate PE has_pe methylene blue MEDRT N0000009782 Oxygen Carrying Capacity Alteration PE has_pe methylene blue MEDRT N0000009845 Small Intestine Fluid/Electrolyte Absorption Alteration PE has_pe sodium phosphate, monobasic
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.12 MG / 81 MG / 10.8 MG / 32.4 MG / 40.8 MG ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES PRESCRIBABLE Y ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 ATTRIBUTES TTY SBD CODES MMSL_CODE BD30291 CODES RxCUI 1048340 CODES SPL_SET_ID 1d80a11c-6f86-403b-85d4-32ec1924dbe9 NAMES Prescribable Synonym urelle Urinary Antiseptic 0.12 MG / 81 MG / 10.8 MG / 32.4 MG / 40.8 MG Oral Tablet NAMES RXNAV_STR Urelle (hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet NAMES RxNorm Name hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urelle] NAMES RxNorm Synonym Urelle (hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG) Oral Tablet SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon